Research
Molecular
Recent innovations in bariatric research include pharmacological therapies targeting GLP-1 receptors, minimally invasive procedures, and genetic and microbiome-based strategies.
These innovations may provide new options for obesity treatment.
StrongSupportsmedium confidence
Innovations in bariatric research were categorized into three main domains: (1) pharmacological therapies targeting glucagon-like peptide-1 (GLP-1) receptors, lipolysis, and metabolic pathways; (2) minimally invasive endoscopic and device-assisted interventions; and (3) novel genetic and microbiome-based strategies.
Why this rating
Based on systematic review methodology.
Source
Chemobiology of Obesity and Advances in Bariatrics: A Systematic Review
Chinua Onyebuchi et al. · medtigo Journal of Medicine · 2025
Meta-analysisCited 2×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →